Marketwire - Medical and Healthcare

ALDA Pharmaceuticals to Undertake Non-Brokered Private Placement

Fri, 03 Jul 2009 14:59:00 EDT

VANCOUVER, BRITISH COLUMBIA--(Marketwire - July 3, 2009) - ALDA Pharmaceuticals Corp. (TSX VENTURE:APH)(OTCBB:APCSF) (the "Company") announces that it is undertaking a non-brokered private placement of up to 3 million units of the Company (the "Units") at a price of $0.20 per Unit for proceeds to the Company of up to $600,000. Each Unit consists of one common share of ALDA and one non-transferable share purchase warrant entitling the holder to acquire one additional common share of ALDA at a price of $0.40 per common share for a period of twelve (12) months from the date of the issuance of the purchase warrant with a forced exercise provision attached to each warrant commencing on the day following the expiry of any applicable hold period on the underlying Common Share, stating that if, for ten consecutive trading days, the closing price of the listed shares of the Company exceeds $0.80 then the exercise period of the warrants will be reduced to a period of 10 days following such tradi

LIVESTRONG(R) Global Cancer Campaign Debuts in France

Fri, 03 Jul 2009 14:44:00 EDT

Lance Armstrong Foundation Celebrates With Monaco Cancer Fundraiser, New Campaign Commitment by France's La Ligue nationale contre le cancer

L'Association pulmonaire invite les Canadien-nes � demander des vols d'avion sans animaux

Fri, 03 Jul 2009 10:57:00 EDT

Elle lance une campagne en-ligne pour inciter le Parlement � l'action

Lung Association Calls on Canadians to Take Action for Pet-Free Flights

Fri, 03 Jul 2009 10:57:00 EDT

Launches online campaign to push Parliament to act on pet-free flights

Dental Marketing Company, Sinai Marketing, Inc., Is Ready for Bing.com

Fri, 03 Jul 2009 10:27:00 EDT

BOULDER, CO--(Marketwire - July 3, 2009) - Microsoft's new search engine, Bing.com, is gaining momentum in the Web industry. Although Bing is still in its infancy, the arrival of a new search engine poses new challenges for Web optimization and search engine optimization (SEO) companies. However, Sinai Marketing, Inc., industry experts in dental marketing, is poised for new search engines and changes to the Web industry.

Even though Sinai's optimization techniques are custom-made for top search engines such as Google and Yahoo!, their methods for SEO (Google) are proving successful even in new search engines such as Bing.

Diabetes Can Be Treated -- Without Drugs: Julian Whitaker, MD, to Speak on Drug-Free Strategies for Lowering Blood Sugar and Preventing Complications

Fri, 03 Jul 2009 09:00:00 EDT

NEWPORT BEACH, CA--(Marketwire - July 3, 2009) - Nearly 24 million Americans, or 7.8 percent of the US population, are afflicted with diabetes, and it's taking its toll. Diabetes is a leading cause of blindness, amputations, kidney failure, nerve damage, cardiovascular disease, and premature death. Although most physicians recommend lifestyle changes for their patients with diabetes, they are also quick to pull out the prescription pad. Julian Whitaker, MD, founder of the Whitaker Wellness Institute, the largest alternative medicine clinic in the US, and author of the best-selling book, Reversing Diabetes, disagrees with this strategy.

Imaging3 to Host "State of the Company" Conference Call

Fri, 03 Jul 2009 07:00:00 EDT

BURBANK, CA--(Marketwire - July 3, 2009) - Imaging3T, Inc. (OTCBB: IMGG), developer of a breakthrough medical imaging device that produces 3D medical diagnostic images of virtually any part of the human body in real-time, announced today that on Monday, July 6, 2009 at 11:00am PDT, the company's CEO, Mr. Dean Janes, will be hosting a conference call to provide an update on the company's plans as well as an update on FDA approval progress.

Novo Nordisk A/S -- Regulatory Approval

Fri, 03 Jul 2009 04:49:00 EDT

BAGSVAERD, DENMARK--(Marketwire - July 3, 2009) - Novo Nordisk's Victoza� (liraglutide) receives marketing authorisation in Europe

Novo Nordisk announced today that the European Commission has granted marketing authorisation for Victoza� for the treatment of type 2 diabetes in adults. The authorisation covers all 27 European Union member states.

Victoza� is the brand name approved in Europe for liraglutide, the first once-daily human Glucagon-Like Peptide-1 (GLP-1) analogue developed for the treatment of type 2 diabetes. The marketing authorisation covers:

HearAtLast to Develop 25 New Hearing Store Locations in the USA and Canada

Thu, 02 Jul 2009 21:54:00 EDT

MISSISSAUGA, ON--(Marketwire - July 2, 2009) - HearAtLast Holdings, Inc. (PINKSHEETS: HRAL), a leading provider of suitable affordable solutions to clients with hearing needs in the billion dollar hearing loss market, announced today it will be developing 25 new Hearing Store locations in various markets in the USA and Canada. These new locations will be by way of a joint venture agreement between certain Joint Venture Partners and HearAtLast Holdings, Inc.

This Independence Day, Exercise Your Freedom to Know the Quality of Health Care You Are Getting

Thu, 02 Jul 2009 19:41:00 EDT

California's Health Care Quality Report Card Helps Consumers Get the Most Out of Their Health Care

Declare Your Independence and Stop Smoking for Good This Fourth of July

Thu, 02 Jul 2009 19:12:00 EDT

LA County Residents Can Visit Their Local Ralphs Pharmacy for Free Nicotine Patches or Gum, While Supplies Last

CNS Response Files Action Against Its Former CEO

Thu, 02 Jul 2009 14:22:00 EDT

COSTA MESA, CA--(Marketwire - July 2, 2009) - CNS Response, Inc. (OTCBB: CNSO) today announced that it has filed an action in the United States District Court for the Central District of California against Len Brandt, the Company's former CEO, who was terminated on April 10, 2009, and certain others. In the action, captioned CNS Response, Inc. v. Leonard Brandt, EAC Investment LP and EAC Investment, Inc., CNS Response alleges that Mr. Brandt and the other defendants have violated federal securities laws in connection with their solicitation of proxies and written consents and attempts to call and hold a special meeting in lieu of the annual meeting of stockholders.

SRS Applauds CCHIT for Listening to the Voice of the Physician

Thu, 02 Jul 2009 13:29:00 EDT

Making "Meaningful Use" Attainable Will Increase Adoption

CommuniCare Health Centers Receives Capital Improvement Grant

Thu, 02 Jul 2009 13:14:00 EDT

Local Non-Profit Receives a $1.4 Million Grant to Help Fund Construction of New Health Center in Kyle, Texas

International Drug & Explosives Detection Firm IDenta Corp. Releases Update on Marketing Trip

Thu, 02 Jul 2009 12:39:00 EDT

JERUSALEM--(Marketwire - July 2, 2009) - IDenta Corp. (PINKSHEETS: IDTA) today released an update of the recent marketing trip.

CEO Yaacov Shoham states, "All of the scheduled meetings in the US and France have been held and the results were very successful. The meetings were well organized and involved a lot of important decision makers. This was by far the most important business trip since we started our worldwide marketing program. Everyone who has seen a demonstration of the Identa's different kits, including the new General Drug Screening Kit, has been very impressed."

Compass Clinical Consulting Launches BETTER HOSPITALS Resource Site

Thu, 02 Jul 2009 12:36:00 EDT

Patient Care, Cost Management, Compliance, Accreditation, Executive Leadership to Be Featured Topics

REMINDER: Webcast Double Feature Showcases Treatment Options at NewYork-Presbyterian Hospital for Patients With Aortic Aneurysms

Thu, 02 Jul 2009 10:30:00 EDT

ORLive Invites Vascular Surgeons, Cardiothoracic Surgeons, Interventional Cardiologists, Interventional Radiologists, Cardiologists, Primary Care Physicians, Patients and Care Seekers to Its First-Ever Back-to-Back Live Interactive Webcast on Wednesday, June 24, at 7:00PM

Demonstrations and Discussions of Continuum of Care for Aortic Aneurysms and Dissections Featuring Endovascular Approach Using Investigational "Fenestrated" Endograft and Open Surgery

Extensive and Rapid Diagnostic Assay for Herpesviral Infections in the Central Nervous System

Thu, 02 Jul 2009 10:16:00 EDT

HELSINKI, FINLAND--(Marketwire - July 2, 2009) -

Mobidiag's CE-IVD-marked Prove-itT Herpes-test helps the clinician in targeting antiviral treatment correctly for patients with severe herpesviral infections

Helsinki, Finland - June 2, 2009 - Finnish biotech company Mobidiag announces CE-marked herpesvirus microarray for rapid In Vitro Diagnostics (IVD) of life-threatening central nervous system infections. The achieved certificate ensures the safety of the product in clinical use and opens European markets for the company. Prove-itT Herpes identifies seven herpesviruses in a single assay, whereas most current methods search for only one virus at a time, or are unable to identify all viruses covered by Mobidiag's assay.

MMR Information Systems Announces July 14 Investor Call

Thu, 02 Jul 2009 08:50:00 EDT

LOS ANGELES, CA--(Marketwire - July 2, 2009) - MMR Information Systems, Inc. (OTCBB: MMRF) (the "Company"), which through its wholly-owned operating subsidiary, MyMedicalRecords, Inc. ( "MMR") provides consumer-controlled Personal Health Records ("PHRs") (www.mymedicalrecords.com) and electronic safe deposit box storage solutions (www.myesafedepositbox.com), announced today that it has scheduled an Investor Call on Tuesday, July 14, at 11:30 a.m. Pacific Time (U.S. and Canada).

Non-Toxic Pain Reliever Offers Safe Alternative to Harmful Painkillers

Thu, 02 Jul 2009 08:41:00 EDT

FDA Issues Warnings to Pull Vicodin and Percocet; FDA Increases Warnings for Acetaminophen and NSAIDs; StayActiv(R) Delivers Pain Relief Without Dangerous Side Effects

CNS Response Provides Third Quarter Corporate Update

Thu, 02 Jul 2009 08:00:00 EDT

Annual Meeting of Stockholders to Be Held September 2009

Micrel Extends Performance and Saves Cost With New Synchronous Hyper Speed Control(TM) Family of PWM Controllers

Thu, 02 Jul 2009 07:00:00 EDT

New Architecture Dramatically Reduces Output Capacitance and Features Excellent Transient Response for High Delta V Operation

Major Japanese Robot Developer Seeks Discussions With U.S. Mobile Robot Co.

Thu, 02 Jul 2009 06:00:00 EDT

CONYERS, GA--(Marketwire - July 2, 2009) - GeckoSystems Intl. Corp. (PINKSHEETS: GCKO) announced today that a major Japanese mobile service robot developer has expressed interest in licensing GeckoSystems' "Mobile Robot Solutions for Safety, Security, and Service"T for manufacturing and distribution in Japan.

Martin Spencer, President/CEO of GeckoSystems stated: "As all of us here at GeckoSystems are excited about this development, due to the nature of the upcoming discussions I feel it is in the best interest of all parties involved to withhold the name of the Japanese company at this time. The upcoming meeting and the potential outcome(s) of it is something that has been in the works for several years and is now coming to what looks to be an extraordinarily profitable culmination. I believe their interest in us is due to not only our flagship product, the automatic self navigation software, GeckoNav

Kitzhaber Is First WesternU Pumerantz Lecture Speaker

Thu, 02 Jul 2009 06:00:00 EDT

POMONA, CA--(Marketwire - July 2, 2009) - Western University of Health Sciences has named John Kitzhaber, MD, former governor of Oregon, as its inaugural speaker for the Dr. Philip Pumerantz Distinguished Lectureship in Interprofessional Education.

Dr. Kitzhaber's topic will be "The Unfinished Business of the Baby Boom Generation: Health Care for the 21st Century." His presentation will be at 6:30 p.m. Thursday, Oct. 1, 2009, on the WesternU campus in Pomona.

The lectureship, in honor of WesternU's founder and president, Dr. Philip Pumerantz, was established earlier this year as part of a $5.1 million pledge to WesternU by Drs. Daljit and Elaine Sarkaria of Orange.

Medical Marijuana, Inc. Signs the First Cannabis Collective in Venice, California to Use Tax Remittance Card

Thu, 02 Jul 2009 04:20:00 EDT

MARINA DEL REY, CA--(Marketwire - July 2, 2009) - Medical Marijuana, Inc. (PINKSHEETS: MJNA) expands into Venice, California by signing "99 High Art Collective," which will begin to implement Medical Marijuana, Inc.'s tax remittance card in 4th quarter 2009. "The high energy marketing efforts of our Agents are building major momentum, moving us full steam ahead, as we now have 13 Cannabis Collectives who have agreed to use our Tax Remittance Card," says Rob Griffin, Chief Operations Officer of Medical Marijuana, Inc.

Russian Academy of Science Selects Zecotek Lasers for New Areas of Research

Thu, 02 Jul 2009 03:00:00 EDT

VANCOUVER, BRITISH COLUMBIA--(Marketwire - July 2, 2009) - Zecotek Photonics Inc. (TSX VENTURE:ZMS)(FRANKFURT:W1I), a developer of leading-edge photonics technologies for medical, industrial and scientific markets, today announced that its proprietary Green Fiber Laser GFL 550 has been selected by the Russian Academy of Sciences (Novosibirsk) as the main laser source for Raman spectrometers in solid-state research and for confocal microscopy in biomedical (DNA) research. The lasers will also be used in a program of biomedical research for the development of new tools for confocal microscopy and flow cytometry.

FDA Black Box Warning for Pfizer Smoking Cessation Drug Chantix(R); Cory Watson Crowder and DeGaris Charges Pfizer Knew of Potential Chantix Dangers

Wed, 01 Jul 2009 19:39:00 EDT

BIRMINGHAM, AL--(Marketwire - July 1, 2009) - The FDA has mandated a "Black Box Warning" requiring Pfizer Inc., manufacturer of Chantix�, to strengthen warnings about the health risks and dangers associated with using the drug. Chantix� (varenicline) is advertised as an aid to help people quit smoking. The order for a Boxed Warning comes on the heels of reports linking Chantix� to serious injuries and death. FDA officials noted, "These reports included those with a temporal relationship between the use of [Chantix] and suicidal events and the occurrence of suicidal ideation and suicidal behavior in patients with no history of psychiatric disease." In addition to requiring a stronger Boxed Warning, the FDA is requiring Pfizer to "develop patient Medication Guides highlighting the risk of serious neuropsychiatric symptoms." The FDA Advisory also requires new "Black Box" warnings to be included on packages of smoking

Scottsdale Healthcare Joins VHA Purchasing Network to Improve Supply Cost Management

Wed, 01 Jul 2009 14:29:00 EDT

IRVING, TX--(Marketwire - July 1, 2009) - Scottsdale Healthcare, a three-hospital health system based in Scottsdale, Ariz., has joined VHA Inc., a national health care network, to take its efforts to drive efficiency and improve the quality of care it offers patients to new levels.

Scottsdale Healthcare executives said they based their decision on the strength of VHA's supply chain management program, the breadth of its clinical improvement services and the opportunities VHA provides to network with other leaders across the VHA alliance. The competition among health care alliances and GPOs to work with Scottsdale Healthcare was tough, the executives said, a signal of both the robust options in the marketplace and the strength of the VHA proposal.

Medical Technology VCs Are Optimistic About Obama Administration's Health Care Goals at Elsevier Business Intelligence's 'IN3 East' Partnership/Investment Meeting for Medtech Execs

Wed, 01 Jul 2009 14:24:00 EDT

BOSTON, MA--(Marketwire - July 1, 2009) - Elsevier Business Intelligence announced today that leading venture capitalists who participated in the keynote panel discussion which kicked-off its annual 'IN3 East' strategic partnership and investment meeting are optimistic about the effect that the Obama administration's health care goals will likely have on the medtech industry.

"Generally speaking, medical devices as a category are not likely to be targeted... and it is likely to be part of the solution, in my view," said Paul LaViolette, Venture Partner, SV Life SciencesT. "The less-invasive revolution is going to continue for a long time. It is a means by which to provide cost-effective care. There are huge categories of disease that can be positively affected by this. Large companies are not going to innovate, generally speaking. They are still go

American Diabetes Association Names David M. Kendall, MD, as Organization's New Chief Scientific and Medical Officer

Wed, 01 Jul 2009 12:25:00 EDT

ALEXANDRIA, VA--(Marketwire - July 1, 2009) - The American Diabetes Association announced today that David M. Kendall, MD, has been named Chief Scientific and Medical Officer for the American Diabetes Association, effective September 21, 2009. Dr. Kendall is currently Medical Director and Chief of Clinical and Professional Services at the International Diabetes Center in Minneapolis, MN, and succeeds Richard A. Kahn, PhD, who retired from the Association on June 30, 2009.

As Chief Scientific and Medical Officer for the American Diabetes Association, Dr. Kendall will provide oversight for the Association's research grant program, certification programs, clinical guidelines, professional education programs, and general information resources.

Vision Loss Linked to Blocked Blood Vessels in Some Glaucoma Patients; Inflammation Impacts Corneal Transplants in Herpes Patients

Wed, 01 Jul 2009 11:30:00 EDT

Research Highlights of the July 2009 Issue of "Ophthalmology"

Emergisoft Selling Complaint-Specific Forms for a Fraction of the Cost of Traditional Paper Charting Solutions

Wed, 01 Jul 2009 11:22:00 EDT

ARLINGTON, TX--(Marketwire - July 1, 2009) - Emergisoft is pleased to announce the release of the EC Forms Paper Charting Solution. For an introductory period, Emergisoft is offering a 3-year, unlimited use license of the EC Forms for the cost of $10,000 per facility. The promotional price is about 90% less than the cost of traditional paper charting solutions.

Emergisoft's comprehensive, complaint-specific physician documentation system drives emergency department efficiency and productivity by giving ER physicians a quick, intuitive, paper charting solution. The EC Forms are available for unlimited physicians and unlimited visits at each facility.

Allied Healthcare International Inc. Elects Dr. Jeffrey S. Peris as Non-Executive Chairman of the Board

Wed, 01 Jul 2009 10:42:00 EDT

NEW YORK, NY--(Marketwire - July 1, 2009) - Allied Healthcare International Inc. (NASDAQ: AHCI) (AIM: AHI) (http://www.alliedhealthcare.com), a leading provider of flexible healthcare staffing services in the United Kingdom, has elected Dr. Jeffrey Peris as its non-executive Chairman of the Board.

Dr. Peris has been a director of Allied since May 1998 and the interim non-executive chairman of the board since April 2009. Since May 2006, Dr. Peris has served as an executive advisor to leading established global and new business entities. Dr. Peris served as the corporate vice president of human resources and chief learning officer of Wyeth (formerly American Home Products Corporation), a global pharmaceutical company, from 2001 until 2006. Dr. Peris was a corporate vice president of Knoll Pharmaceutical (Abbott L

Reimbursement Landscape Demands Health Outcomes Research Earlier in Development, Says Cutting Edge Information

Wed, 01 Jul 2009 10:15:00 EDT

RESEARCH TRIANGLE PARK, NC--(Marketwire - July 1, 2009) - Stringent payer demands are causing companies to reprioritize health outcomes and cost-effectiveness data from post-launch and integrating them into clinical development, according to a newly released Cutting Edge Information study on payer relationship management.

The study "Securing Market Access: Reimbursement, Payer Relationships and Healthcare Reform" (http://www.cuttingedgeinfo.com/market-access) finds that, on average, cost-effectiveness studies cost $165,000; cost-benefit analysis studies, $27,000. Conducting pharmacoeconomic research in early development can result in significant cost-savings, helping to prevent delays to launch. It can also avoid Phase 4 studies, which can cost up to $175,000.

Genetic Immunity, InPlay: Company Completes Patient Enrollment in Italian Phase II Trial of DermaVir Patch HIV Immunotherapeutic Nanomedicine

Wed, 01 Jul 2009 10:05:00 EDT

BUDAPEST, HUNGARY--(Marketwire - July 1, 2009) - Power of the Dream Ventures, Inc. (OTCBB: PWRV), Hungary's premier technology acquisition and development company, is pleased to present this Genetic Immunity release, based on a previously announced agreement whereby Power of the Dream Ventures will issue communications for Genetic Immunity on a going forward basis.

Genetic Immunity is pleased to announce completion of patient enrollment in the Company's Phase II randomized, placebo-controlled trial designed to investigate whether therapeutic immunization during highly active antiretroviral therapy (HAART) induces elevations of HIV-specific T cell precursors with high proliferative capacity (PHPC) in HIV-1-infected individuals, and whether the quantity of PHPC correlates with the viral load set point following analytical treatment interruption (ATI). This second Phase II study is conducted at the IRCCS Policlinico S.

BioElectronics Corp.'s Patented ActiPatch(R) Therapy and Allay(TM) Patches Are Safe and Effective Alternatives to Acetaminophen

Wed, 01 Jul 2009 10:00:00 EDT

Management and Leading Physicians Comment on FDA Panel Recommendation

MattsonJack Adds Indications to Epi Database

Wed, 01 Jul 2009 09:23:00 EDT

Pharma's Gold-Standard Epidemiology Data Set in G7 Countries and Emerging Markets of Brazil, Russia, India, and China

Cardioxyl Pharmaceuticals Initiates Phase I/IIa Study in Heart Failure

Wed, 01 Jul 2009 08:30:00 EDT

Study to Evaluate the Safety and Tolerability of Lead Candidate, CXL-1020, in the Treatment of Cardiovascular Disease

CNS Response Addresses "Notice of Special Meeting of Stockholders of CNS Response, Inc." Mailings

Wed, 01 Jul 2009 08:00:00 EDT

COSTA MESA, CA--(Marketwire - July 1, 2009) - CNS Response, Inc. (OTCBB: CNSO) (the "Company") is issuing this press release in order to provide its stockholders with information regarding one or more communications that they may have received in the mail captioned "Notice of Special Meeting of Stockholders of CNS Response, Inc." These communications, purporting to call a special meeting of Company stockholders, were neither authorized nor mailed to stockholders by the Company. Rather, the communications were mailed by the former Chief Executive Officer of the Company, Leonard Brandt, who was dismissed from that position by the Board of Directors on April 10, 2009. Mr. Brandt is attempting to call the meeting pursuant to the provisions of the bylaws of the Company that permit stockholders holding at least 1/4 of its outstanding shares to call a special meeting of stockholders.

Truestone's Ken Bodenheimer Named President of HIMSS - National Capital Area

Wed, 01 Jul 2009 08:00:00 EDT

FAIRFAX, VA--(Marketwire - July 1, 2009) - Truestone, LLC is pleased to announce that Ken Bodenheimer became President of the Health Information Management and Systems Society (HIMSS) National Capital Area Chapter on July 1, 2009. HIMSS is the leading healthcare IT association and played a key role in obtaining $37 billion in stimulus funding for the creation of a nationwide network of electronic health records.

Bodenheimer has been a member of HIMSS-NCA for 5 years and recently served as Vice President. His 30-year career in the healthcare industry spans clinical, financial and administrative systems and informatics -- in both the federal and commercial markets. Mr. Bodenheimer has held management positions at Abbott Laboratories, First Coast Systems and MediSolutions.

Heathrow Natural Food & Beverage, Inc. to Begin Distribution of ACAI Plus Chewing Gum on September 1, 2009

Wed, 01 Jul 2009 07:30:00 EDT

LAKE MARY, FL--(Marketwire - July 1, 2009) - Heathrow Natural Food & Beverage, Inc. (PINKSHEETS: HRNF) is pleased to announce it will begin initial distribution of its Super Food brand functional chewing gum ACAI Plus beginning September 1, 2009. Distribution will include the North East & South East United States, United Kingdom & Ireland, Euro Zone, Japan and Australia. HNFB expects to ship four million units over the first six months of distribution. ACAI Plus will be available in convenience stores, drug chains, nutritional chains, big box stores and supermarkets. HNFB is in the final stages of testing its trial production run which will be shipped as samples beginning mid to end of July 2009. Two ACAI Plus Chiclets will deliver 17,000 ORAC or the equivalent of three pints of blueberries.

Online Legal Steroids Announces HGH Factor: Non-Injectable Human Growth Hormone in Tablet Form

Wed, 01 Jul 2009 06:00:00 EDT

ST. PETERSBURG, FL--(Marketwire - July 1, 2009) - Online Legal Steroids, a leading online supplier of muscle enhancers, bodybuilding supplements and legal steroids products, has announced that a new product, HGH Factor, will be added to OnlineLegalSteroids.com.

HGH for injection is one of the most expensive drugs in the United States, with a cost that can range between $800 and $3,000 per month. HGH Factor is taken in tablet form with no needles and no doctor's prescription necessary. HGH Factor is about 80% cheaper than human growth hormone while still retaining all of the benefits.

StockGuru.com Announces a New Executive Interview Featuring CEO and Colorful Television Pitchman Danny Alex of Muscle Flex Inc.

Wed, 01 Jul 2009 05:00:00 EDT

DALLAS, TX--(Marketwire - July 1, 2009) - (PINKSHEETS: MFLI) John Pentony, Publisher of Stockguru.com, announced today that it has posted a new Podcast Interview featuring the CEO and colorful television pitchman for Muscle Flex Inc., Danny Alex.

To listen to the StockGuru.com interview with Danny Alex, please visit:

http://www.stockguru.com/2009/07/Danny_Alex/

Novo Nordisk A/S -- Treasury Stock

Wed, 01 Jul 2009 04:52:00 EDT

BAGSVAERD, DENMARK--(Marketwire - July 1, 2009) - Status regarding Novo Nordisk's holding of its own shares (30 June 2009)

In continuation of the company's announcement dated 29 January 2009 concerning a planned share repurchase programme, and pursuant to Section 204.25 of the New York Stock Exchange Listed Company Manual, this is to report that Novo Nordisk A/S (NYSE: NVO) and its wholly-owned affiliates on 30 June 2009 owned 19,326,741 of its own B shares of DKK 1, corresponding to a total nominal value of DKK 19,326,741 or 3.12% of the total share capital.

CEGEDIM : Acquisition of the NOMI Group

Wed, 01 Jul 2009 02:45:00 EDT

PARIS--(Marketwire - July 1, 2009) - A deal focusing on reinforcing its position in the nordic area (Sweden, Norway, Finland & Denmark)

Cegedim, the world leader in CRM (Customer Relationship Management) solutions for the pharmaceutical industry, announces the acquisition from Bisnode of the Nomi Group, one of the first solution providers for business intelligence and sales effectiveness dedicated to the pharmaceutical industry in the Nordic region.

Founded in Sweden in 1984, the Nomi Group provides a full range of solutions and services enabling stakeholders of the pharmaceutical industry to optimize their actions designated for prescribing physicians. Organized in three business units: healthcare professionals databases, CRM, market research and prescription studies, the offer of Nomi covers today entire Nordic region (Sweden, Norway, Finland and Denmark).

Pharming confirms positive results from final analysis of Rhucin(R) studies

Wed, 01 Jul 2009 02:00:00 EDT

LEIDEN, NETHERLANDS--(Marketwire - July 1, 2009) -

Leiden, The Netherlands, July 1, 2009. Biotech company Pharming Group NV ("Pharming" or "the Company") (NYSE Euronext: PHARM) today announced that, as part of the activities for the regulatory submission files, it has now also completed the final analysis of its Rhucin� randomised placebo-controlled studies. The results confirm the positive and consistent efficacy and safety of Rhucin in the treatment of acute angioedema attacks in patients with Hereditary Angioedema (HAE).

Statement From the Consumer Healthcare Products Association on Today's Joint FDA Advisory Committee Recommendations on Over-the-Counter Medicines Containing Acetaminophen

Tue, 30 Jun 2009 19:00:00 EDT

WASHINGTON, DC--(Marketwire - June 30, 2009) - Following is a statement by Linda A. Suydam, D.P.A., president of the Consumer Healthcare Products Association (CHPA), regarding the recommendations issued today by the U.S. Food and Drug Administration's Drug Safety and Risk Management Advisory Committee, Nonprescription Drugs Advisory Committee, and the Anesthetic and Life Support Drugs Advisory Committee. The joint committee addressed the use of over-the-counter (OTC) and prescription (Rx) drugs containing acetaminophen.

On the Path Productions -- Health Info-entials in Action

Tue, 30 Jun 2009 18:17:00 EDT

SAN FRANCISCO, CA--(Marketwire - June 30, 2009) - Health Info-entialsT, a term coined by Edelman Public Relations, is the word du jour for communication and social media professionals, but for Christopher Springmann, experiencing the active synergy of interested parties and information technology beats new buzzwords any day.

"The San Francisco Chronicle ran a very flattering story on our Life Love & Health daily show on Monday morning," said Springmann, Executive Producer of On The Path Productions LLC, a San Francisco health media company. "Yet, a Google alert about the article hit my inbox before the paper hit the porch, while multiple Twitters about the piece found me first at Starbucks. That's amazing."

AeroGrow Reports Results for Fourth Quarter and Year Ending March 31, 2009

Tue, 30 Jun 2009 17:30:00 EDT

Revenue of $5.9 Million for the Quarter; Revenue of $37.4 Million for the Full Year; $7.6 Million Recapitalization Completed June 30, 2009

AeroGrow Completes $6.3 Million Private Placement

Tue, 30 Jun 2009 17:30:00 EDT

BOULDER, CO--(Marketwire - June 30, 2009) - AeroGrow International, Inc. (OTCBB: AERO) (the "Company" or "AeroGrow") makers of the AeroGarden line of indoor gardening products, announced that it has completed a private placement in which the company raised cash or converted other obligations or existing loans in excess of $6.3 million through the issuance of Series A preferred stock and warrants to accredited and institutional investors.

AeroGrow Completes $7.6 Million Recapitalization

Tue, 30 Jun 2009 17:30:00 EDT

BOULDER, CO--(Marketwire - June 30, 2009) - AeroGrow International, Inc. (OTCBB: AERO) (the "Company" or "AeroGrow") makers of the AeroGarden line of indoor gardening products, announced that it has successfully completed a $7.6 million recapitalization including the conversion of accounts payable to long-term debt, the amendment of terms of its senior secured revolving credit facility, and other fundraising as detailed in concurrent releases today.

Savaria Corporation Issuer Bid

Tue, 30 Jun 2009 17:09:00 EDT

LAVAL, QUEBEC--(Marketwire - June 30, 2009) - Savaria Corporation ("Savaria" or the "Corporation") (TSX:SIS), the second largest company in the accessibility industry in North America, today announced that it has commenced with the issuer bid for up to 4,000,000 common shares (14.8% of the issued and outstanding common shares) at a price of C$0.90 per share with a 35 day deposit period expiring on August 4, 2009 ("Issuer Bid'). Savaria currently has 27,061,014 common shares issued and outstanding.

HearAtLast Establishes Advisory Board to Manage Growth Opportunities and Appoints First Two Members

Tue, 30 Jun 2009 16:19:00 EDT

MISSISSAUGA, ON--(Marketwire - June 30, 2009) - HearAtLast Holdings, Inc. (PINKSHEETS: HRAL), a leading provider of suitable affordable solutions to clients with hearing needs in the billion dollar hearing loss market, announced today the formation of its advisory board with the appointment of Louie Mele, consultant and former CEO of McDonald's Canada, and Gora Ganguli, President & CEO of VitaSound Audio, Inc.

Matthew Sacco, CEO of HearAtLast, commented, "The board was created to add depth to the management team and gather knowledge from experienced business professionals and select individuals within the industry. This will increase HearAtLast's capabilities while exploring new opportunities to enhance shareholder value, business development and growth."

Myriad Genetics Announces Preliminary Revenue Results for Fiscal 2009 Fourth Quarter, Full Year

Tue, 30 Jun 2009 16:05:00 EDT

SALT LAKE CITY, UT--(Marketwire - June 30, 2009) - Myriad Genetics, Inc. (NASDAQ: MYGN) today announced that, based on preliminary estimates, it anticipates reporting total molecular diagnostic revenue, which represents the bulk of the Company's revenue, of approximately $86 million for the fiscal 2009 fourth quarter ending June 30, 2009. The Company continues to believe that revenue for the fiscal 2009 fourth quarter is being impacted by the current economic recession, which is driving increasing unemployment levels resulting in the loss of insurance coverage and patients delaying or cancelling doctor visits.

Los Angeles Clinics and Celebrities Band Together to Fight Health Care Cuts; Joint Statement From The Saban Free Clinic, Venice Family Clinic and Westside Family Health Center

Tue, 30 Jun 2009 14:54:00 EDT

Call to Action Urges Californians to "Call Sacramento Now!"

RCN to Sponsor American Diabetes Association's Step Out: Walk to Fight Diabetes Event in Washington, D.C. Area

Tue, 30 Jun 2009 14:52:00 EDT

Company Donates Advertising Time in Its Washington, D.C. Market to Promote 'Step Out' & Tour de Cure Local Fundraising Events

The Multiple Sclerosis Association of America's Interactive Video Series Wins Prestigious Business Award

Tue, 30 Jun 2009 14:32:00 EDT

CHERRY HILL, NJ--(Marketwire - June 30, 2009) - The Multiple Sclerosis Association of America's (MSAA) educational web video series, "A Closer Look," recently won the highly acclaimed Stevie Award in the category of Interactive Multimedia/Public Information. This video series has become the cornerstone of MSAA's educational video initiative, MSi (Multiple Sclerosis information), which includes 16 on-demand video programs. Program topics cover medical, family, lifestyle, disability, and legal issues. Individuals with MS or those interested in learning about MS may access these award-winning videos by visiting http://www.msassociation.org/programs/videos/

Goodroe Continues Record as Only Government-Approved Gainsharing Solution

Tue, 30 Jun 2009 14:01:00 EDT

Receives Fourteenth Approval, Supports Obama Administration's Reform Efforts

Dental Cost Containment Company P&R Dental Strategies Appoints Dr. David E. Kilber as Executive Vice President of Business Development

Tue, 30 Jun 2009 11:36:00 EDT

NEW YORK, NY--(Marketwire - June 30, 2009) - P&R Dental Strategies, Inc. (P&R), a premier dental cost containment company, has appointed Dr. David E. Kilber as Executive Vice President of Business Development. In this position, Dr. Kilber will direct strategic planning efforts, and help develop and troubleshoot Utilization Management programs for P&R clients. He will lead development efforts to position P&R to continue as the leader in dental cost control and containment solutions. Dr. Kilber will facilitate the use of P&R's database and analytic tools to enable customers to make more intelligent business decisions with respect to cost savings and increased productivity.

HQ Sustainable Announces Exercise of Over-Allotment Option by Underwriters

Tue, 30 Jun 2009 11:08:00 EDT

SEATTLE, WA--(Marketwire - June 30, 2009) - HQ Sustainable Maritime Industries, Inc. (NYSE Amex: HQS) ("HQS" or the "Company"), a leader in all natural integrated aquaculture and aquatic product processing, including fish byproduct personal healthcare products, today announced that its underwriter exercised an over-allotment option to purchase an additional 183,750 shares of its common stock, raising an additional $1.5 million in gross proceeds, prior to deducting underwriting discounts and commissions and offering expenses payable by the Company.

Hunt Regional Healthcare, Greenville, TX, to Save $500,000 With New Medline Prime Vendor Supply Agreement

Tue, 30 Jun 2009 10:20:00 EDT

Medline Brand Products and Reduced Distribution Fees Drive Cost Savings

Diagnostic Imaging International Corp.-CTS Sign Two New Daytime Coverage Contracts

Tue, 30 Jun 2009 10:17:00 EDT

LAS VEGAS, NEVADA--(Marketwire - June 30, 2009) - Diagnostic Imaging International Corp. (OTCBB:DIIG) announced today that its wholly owned subsidiary, Canadian Teleradiology Services ("CTS"), has signed two new contracts to supply daytime service to hospitals already receiving nighttime service from CTS. CTS recently signed two new daytime contracts for Teleradiology services. The contracts include specific service for CT reads. CT is a high revenue generating modality that will benefit the bottom line of CTS. The contracts have already begun and the daily study count has been steadily increasing.

2009 Marks 40 Years of Choice and Sexual Empowerment for Women in Canada

Tue, 30 Jun 2009 10:02:00 EDT

Canadian government legalized contraception for birth control in June 1969

Ambient ID Unveils LabTrack(TM) Diagnostic Specimen Tracking Solution

Tue, 30 Jun 2009 10:00:00 EDT

Proven Automatic Identification and Business Information Management Technologies Improve Diagnostic Laboratory Operations, Reduce Testing Costs

Biologics Dominate the Autoimmune Market but Small Molecules Still Have Some Fight Left, Says Cutting Edge Information

Tue, 30 Jun 2009 09:51:00 EDT

RESEARCH TRIANGLE PARK, NC--(Marketwire - June 30, 2009) - Biological drugs are the big winners in the market for autoimmune disorders. According to "Autoimmune Market Forecast to 2014," the latest therapeutic market forecast from Cutting Edge Information, 11 of 14 drugs projected to reach blockbuster status are biologics. In fact, sales of biologics marketed for at least one autoimmune disorder topped $29 billion in 2008. In the same year, small molecules earned only $9 billion.

With projected biologics sales projected to hit $55 billion in 2014, nearly all of the major pharmaceutical companies have acquired or partnered with biotechnology firms to develop biologics with potential in this area.

Optelec Reduces Price of Compact+ Video Magnifier for Low Vision Users

Tue, 30 Jun 2009 09:15:00 EDT

SAN DIEGO, CA--(Marketwire - June 30, 2009) - Optelec US Inc., a world leader in innovative and life-changing assistive technologies for the blind and visually impaired, is now offering a reduced Optelec Compact+ price of $595. The Optelec Compact+, a portable handheld video magnifier, gives low vision users independence in their hands.

The Optelec Compact+ is an on-the-go, ultra compact video magnifier that makes it easy and convenient to read labels, menus, maps, books, directions and more. Available in six different colors including pink, orange, green, black, white and blue, Optelec Compact+ consumers can truly personalize their low vision needs.

Vigilos(R) Releases Version 5.2 of BrightSite(R) Technology

Tue, 30 Jun 2009 09:00:00 EDT

SEATTLE, WA--(Marketwire - June 30, 2009) - Vigilos, Inc. released version 5.2 of its BrightSite� technology today, with benefits applicable to a variety of process-oriented industries.

The BrightSite� product addresses issues that range from connecting a food processing company's production activities to its existing security technologies, allowing them to make measurable improvements in labor optimization, manufacturing, employee welfare, premises security, and safety, to securing thousands of critical sites for the Federal Government.

Medicare Part D Texas Drug Plan Beneficial to Senior Citizens

Tue, 30 Jun 2009 09:00:00 EDT

Medical Reimbursement Resource Assists Seniors in Selecting the Best Plan

Study Finds Edwards Lifesciences' Port Access System Facilitates Improved Outcomes Compared to Sternotomy

Tue, 30 Jun 2009 09:00:00 EDT

BERLIN--(Marketwire - June 30, 2009) - Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves, announced that new research demonstrates that using its minimally invasive PORT ACCESS System in mitral valve surgery significantly decreases the length of stay in hospitals and intensive care units (ICU), and improves other outcomes when compared to conventional sternotomy (an incision the length of the chest). Results were presented today at the Society for Heart Valve Disease 5th Biennial Meeting in Berlin.

New Online Tool From National Headache Foundation Helps People With Headache Take Control, Get Relief

Tue, 30 Jun 2009 09:00:00 EDT

"Headache U" Is First Educational Program of Its Kind, Matches Sufferers With Resources Based on Personal Headache Patterns

Smith & Nephew - Total Voting Rights

Tue, 30 Jun 2009 08:37:00 EDT

London, UK--(Marketwire - June 30, 2009) -



Smith & Nephew plc - Voting Rights and Capital


30 June 2009


In conformity with Rule 5.6.1 of the FSA's Disclosure
and Transparency Rules, we notify the market that as at 30 June 2009:


Smith & Nephew plc's issued share capital with voting rights consists
of 884,093,133 ordinary shares of US20c each.  


65,984,911 ordinary shares are held in treasury, and are not included
in the above figure.


884,093,133 ordinary shares may be used by shareholders for calculating
if they are required to notify their interest in, or change to their
interest in, the Company under the FSA's Disclosure and Transparency
Rules.



Susan Henderson

Company Secretary

                    This information is provided by RNS
          The company news service from the London Stock Exchange

END

AspenBio Pharma Files 510(k) Notification With FDA for AppyScore(TM) Test

Tue, 30 Jun 2009 08:30:00 EDT

Filing Advances AppyScore(TM) Test as the World's First Blood-Based Test to Aid in the Diagnosis of Human Appendicitis

Zola A�a� Teams Up With Robeks to Provide Consumers With the Highest Quality A�a� Products

Tue, 30 Jun 2009 08:00:00 EDT

Awesome A�a� Smoothie, A�a� Energizer Smoothie, and A�a� Especial Bowl Now Contain Zola A�a�

Green Planet Delivers Strong First Quarter 2009 Results

Tue, 30 Jun 2009 07:00:00 EDT

MIAMI, FL--(Marketwire - June 30, 2009) - Green Planet Bioengineering CO., LTD. (OTCBB: GPLB) ("Green Planet" or the "Company"), a leading bioengineering enterprise dedicated to creating high quality chemical intermediates and innovative downstream health products using green processes, reports record first quarter 2009 results.

First quarter 2009 revenue was up 5% to $2,297,621 compared to $2,192,799 for the same period last year. EBITDA (defined as earnings before interest, taxes, depreciation and amortization) was $1,211,679 as compared to $1,239,300 for the same period last year. Operating Income was $1,140,223 compared to $1,130,911 for the same period last year. Net Profit remained relatively flat at $842,725 compared to $862,203 for the same period last year due to an increase in the effective tax rate originating from non taxable subsidy income in 2008.

Major Intl. German Mfg. Seeks Discussions With U.S. Mobile Robot Co.

Tue, 30 Jun 2009 06:00:00 EDT

CONYERS, GA--(Marketwire - June 30, 2009) - GeckoSystems Intl. Corp. (PINKSHEETS: GCKO) announced today that a major, multi-billion dollar German manufacturer has extended an important request to GeckoSystems to meet with their senior management at their corporate headquarters in Conyers, GA. GeckoSystems is a dynamic leader in the emerging Mobile Service Robot industry revolutionizing their development and usage with "Mobile Robot Solutions for Safety, Security and Service�."

Muscle Flex Inc. Expands Its Celebrity Network Through Hollywood Insider GBK Productions

Tue, 30 Jun 2009 05:00:00 EDT

Products Featured at the 2008 GBK Productions Emmy Awards Gifting Suite and Many More Future Star-Studded Events

Medical Marijuana, Inc Captures Market Share in 3 More Counties in California

Tue, 30 Jun 2009 04:20:00 EDT

MARINA DEL REY, CA--(Marketwire - June 30, 2009) - Medical Marijuana, Inc (PINKSHEETS: MJNA) continues its expansion with four additional collectives agreeing to use Medical Marijuana, Inc's tax remittance card. Dianna Kaplan, the marketing consultant assisting MMI says, "The addition of these collectives shows their intent to comply with tax laws and provides a more solid basis to build their business on."

The Healing Centers 1 & 2 in Orange County, California, 2 Green Thumbs in Tuolomne County, California and Mother Nurture Collective in San Diego County, California plan to implement the tax remittance card in September 2009.

Novo Nordisk A/S: Total voting rights

Tue, 30 Jun 2009 04:16:00 EDT

BAGSVAERD, DENMARK--(Marketwire - June 30, 2009) - Total number of voting rights and share capital in Novo Nordisk A/S as of 30 June 2009.

In accordance with Section 6 of the Danish Statutory Order on Issuers Disclosure Obligations, Novo Nordisk is required to publish the total number of voting rights and the size of the share capital in Novo Nordisk as per the end of the month where changes have occurred.

Referring to Company Announcement no 35/2009 dated 22 June 2009, please find below a statement regarding the total number of voting rights and share capital in Novo Nordisk as per 30 June 2009.

Pharming gives update on outstanding number of shares

Tue, 30 Jun 2009 02:01:00 EDT

LEIDEN, NETHERLANDS--(Marketwire - June 30, 2009) -

Biotech company Pharming Group NV ("Pharming") (NYSE Euronext: PHARM) today provided an update on its outstanding number of shares following a transaction with YA Global Master SPV LTD ("YA Global").

Under the Standby Equity Distribution Agreement with YA Global, Pharming issued 1,158,011 ordinary shares for a cash consideration of EUR 0.6 million. As a result of the above transactions, Pharming's total number of outstanding ordinary shares is currently 112,362,987 shares.

Galapagos Awarded Innovative Enterprise Qualification in France

Tue, 30 Jun 2009 01:37:00 EDT

MECHELEN, BELGIUM--(Marketwire - June 30, 2009) - Galapagos NV (Euronext: GLPG) announces that it has been granted the Innovative Enterprise qualification (Entreprises Innovantes au titre des FCPI) from the French governmental organization OSEO that supports innovation and growth of SMEs. French private investors are eligible to receive significant tax advantages for participating in funds which invest in FCPI qualified companies such as Galapagos.

Innovation-focused mutual funds (FCPI) were created by the French 1997 Finance Act in order to support the development of innovative small firms in France. The Act has since been extended and amended to increase the tax benefits gained from holding FCPI units. FCPI funds are subject to approval and audit by the French financial markets authority AMF. Since its inception in 1997, EUR 4.4 billion has been raised by FCPI funds.

TapImmune Announces Corporate Restructuring

Mon, 29 Jun 2009 17:00:00 EDT

BELLEVUE, WA--(Marketwire - June 29, 2009) - TapImmune Inc. (OTCBB: TPIM), a biotechnology company specializing in the development of immunotherapeutics for cancer and vaccines for infectious diseases, announces the appointment of Dr. Glynn Wilson as TapImmune's new Executive Chairman as part of an overall corporate restructuring plan.

Dr. Wilson succeeds Alan Lindsay whom TapImmune Inc. thanks for his service and contributions to TapImmune.

HearAtLast Exclusive Distributor of World's Smallest Standard Fitted CIC Hearing Aid

Mon, 29 Jun 2009 16:50:00 EDT

MISSISSAUGA, ON--(Marketwire - June 29, 2009) - HearAtLast Holdings, Inc. (PINKSHEETS: HRAL), a leading provider of hearing solutions through their Hearing Stores, is pleased to announce its exclusive distribution agreement with ExSilent for Canada. With this new virtually invisible device touted as the "World's Smallest standard fitting CIC," we are confident that this will reach the untapped first-time buyer and more youthful hearing impaired market.

Chembio Presenting DPP(R) Syphilis at ISSTDR Congress

Mon, 29 Jun 2009 16:27:00 EDT

DPP(R) HIV, Hepatitis-C & HIV-Hepatitis Combination Oral Fluid Tests in CDC Study

Worldwide Food Services (EREI) Bids to Supply to UN

Mon, 29 Jun 2009 16:15:00 EDT

BORDENTOWN, NJ--(Marketwire - June 29, 2009) - WORLDWIDE FOOD SERVICES, INC. (Worldwide Food Services) (WWFS) (PINKSHEETS: EREI) is presently in bid competition for a segment of the United Nations' (UN) food supplies. WWFS is also bidding on other grocery items for retailers and large wholesalers in the Middle East and African countries.

For further information about this release, contact Rich Kaiser, Investor Relations, YES INTERNATIONAL, #800-631-8127 and/or www.wwfoodservices.com.

Remedent Reports Fiscal Fourth Quarter and Record Fiscal 2009 Results

Mon, 29 Jun 2009 16:12:00 EDT

Record Annual Net Sales of $14.6 Million, up 96% Year-Over-Year, Driven by 564% Increase in Sales of GlamSmile(TM) Veneers

Electro-Optical Sciences Added to Russell 2000(R) and Russell 3000(R) Indexes

Mon, 29 Jun 2009 16:01:00 EDT

IRVINGTON, NY--(Marketwire - June 29, 2009) - Electro-Optical Sciences, Inc. ("EOS") (NASDAQ: MELA), a medical technology company focused on the design and development of MelaFind�, a non-invasive, point-of-care instrument to assist in the early detection of melanoma, today announced that the company's shares have been added to the Russell 2000� and Russell 3000� indexes, effective immediately.

Membership in the Russell 3000, which remains in place for one year, means automatic inclusion in the Russell 2000 Index as well as the appropriate growth and value style indexes. Member companies are drawn from the 4,000 largest companies meeting the indexes' criteria as of the end of each May and are added or deleted annually as the indexes are reconstituted each June.

Compass Clinical Hospital Accreditation and Compliance Expert Urges Public Comment on CMS Joint Commission Deeming Status

Mon, 29 Jun 2009 14:33:00 EDT

Rare Opportunity for Hospital and Healthcare Leaders to Share Experiences and Suggest Improvements to CMS

Study: On The Right Track Cubicle Curtain System Reduces Hanging and Removal Time From Minutes to Seconds

Mon, 29 Jun 2009 14:09:00 EDT

System Causes Less Physical Stress on Installer Than Traditional Curtain Systems

Lance Armstrong Foundation and American Cancer Society Announce International Partnership to Fight Global Cancer Burden

Mon, 29 Jun 2009 13:53:00 EDT

Organizations Bring Unique Strengths to Form United Front Against Catastrophic "Hidden" Disease

Dr. Ken Harris of Sunderland, Great Britain Has Been Selected as One of 2009's Top Clinical Instructors

Mon, 29 Jun 2009 13:15:00 EDT

SUNDERLAND, UK--(Marketwire - June 29, 2009) - Dr. Ken Harris was featured on the cover of the latest Practical Aesthetics magazine as one of the top clinical instructors worldwide in the field of dentistry in 2009. The featured dentists were selected by the California Center for Advanced Dental Studies (CCADS), an industry leader in postgraduate education.

Dr. Harris's selection was a result of his clinical skills, mentoring efforts and leadership in the field of cosmetic dentistry. "Dr. Harris has proven to be not only an outstanding dentist but also an educator and coach for other dentists looking to advance their cosmetic skills," said Garrett Caldwell, President of CCADS. Dr. Harris will also be leading a bimonthly study group in Northern England to discuss and review aesthetic cases and the latest developments and techniques in dentistry.

Dr. Andrew Chandrapal of Buckinghamshire, Great Britain Has Been Selected as One of 2009's Top Clinical Instructors

Mon, 29 Jun 2009 13:08:00 EDT

BUCKINGHAMSHIRE, UK--(Marketwire - June 29, 2009) - Dr. Andrew Chandrapal was featured on the cover of the latest Practical Aesthetics magazine as one of the top clinical instructors worldwide in the field of dentistry in 2009. The featured dentists were selected by the California Center for Advanced Dental Studies (CCADS), an industry leader in postgraduate education.

Dr. Chandrapal's selection was a result of his clinical skills, mentoring efforts and leadership in the field of cosmetic dentistry. "Dr. Chandrapal has proven to be not only an outstanding dentist but also an educator and coach for other dentists looking to advance their cosmetic skills," said Garrett Caldwell, President of CCADS. He has recently been named the Co-Program Director for the CCADS Live Patient Hands On Program in London. Dr. Chandrapal will also be leading a bimonthly study group in Southern England to discuss and review aesthetic cases and the latest developments and techniques in dentistry.

Dr. Mark Olson of Rocklin, CA Has Been Selected as One of 2009's Top Clinical Instructors

Mon, 29 Jun 2009 13:04:00 EDT

ROCKLIN, CA--(Marketwire - June 29, 2009) - Dr. Mark Olson was featured on the cover of the latest Practical Aesthetics magazine as one of the top clinical instructors worldwide in the field of dentistry in 2009. The featured dentists were selected by the California Center for Advanced Dental Studies (CCADS), an industry leader in postgraduate education.

Dr. Olson's selection was a result of his clinical skills, mentoring efforts and leadership in the field of cosmetic dentistry. "Dr. Olson has proven to be not only an outstanding dentist but also an educator and coach for other dentists looking to advance their cosmetic skills," said Garrett Caldwell, President of CCADS. Dr. Olson co-leads a bimonthly study group to discuss and review aesthetic cases and the latest developments and techniques in dentistry. Dr. Olson also is the co-program director for the CCADS Live Patient Hands-On Program in San Francisco, California and has been an integral part of the success of that prog

Dr. Wilson Kwong of Vancouver, BC Has Been Selected as One of 2009's Top Clinical Instructors

Mon, 29 Jun 2009 13:04:00 EDT

VANCOUVER, BC--(Marketwire - June 29, 2009) - Dr. Wilson Kwong was featured on the cover of the latest Practical Aesthetics magazine as one of the top clinical instructors worldwide in the field of dentistry in 2009. The featured dentists were selected by the California Center for Advanced Dental Studies (CCADS), an industry leader in postgraduate education.

Dr. Kwong's selection was a result of his clinical skills, mentoring efforts and leadership in the field of cosmetic dentistry. "Dr. Kwong has proven to be not only an outstanding dentist but also an educator and coach for other dentists looking to advance their cosmetic skills," said Garrett Caldwell, President of CCADS. He has recently been named the Co-Program Director for the CCADS Live Patient Hands On Program in Vancouver. Dr. Kwong also leads a regular study group in British Columbia to discuss and review aesthetic cases and the latest developments and techniques in dentistry.

Dr. Bryan Judd of Roseville, CA Has Been Selected as One of 2009's Top Clinical Instructors

Mon, 29 Jun 2009 13:01:00 EDT

ROSEVILLE, CA--(Marketwire - June 29, 2009) - Dr. Bryan Judd was featured on the cover of the latest Practical Aesthetics magazine as one of the top clinical instructors worldwide in the field of dentistry in 2009. The featured dentists were selected by the California Center for Advanced Dental Studies (CCADS), an industry leader in postgraduate education.

Dr. Judd's selection was a result of his clinical skills, mentoring efforts and leadership in the field of cosmetic dentistry. "Dr. Judd has proven to be not only an outstanding dentist but also an educator and coach for other dentists looking to advance their cosmetic skills," said Garrett Caldwell, President of CCADS. Dr. Judd leads a bimonthly study group to discuss and review aesthetic cases and the latest developments and techniques in dentistry. Dr. Judd also is the co-program director for the CCADS Live Patient Hands On Program in San Francisco, California and has been an integral part of the success of that program.

Cuando se trata de sus ojos, haga que los suyos sean su "hogar, seguro hogar"

Mon, 29 Jun 2009 12:50:00 EDT

Los resultados de la sexta encuesta anual Eye Injury Snapshot ("Informe de Lesiones Oculares") de la American Academy of Ophthalmology (Academia Estadounidense de Oftalmolog�a) indican que casi la mitad de las lesiones de los ojos ocurre en la casa con proyectos cotidianos

La importancia de usar anteojos de protecci�n es el centro del nuevo anuncio de servicio p�blico del maestro carpintero Norm Abram, de PBS

Jet Edge Exhibiting Latest Waterjet Technology at 2009 American WJTA Conference and Expo

Mon, 29 Jun 2009 12:48:00 EDT

ST. MICHAEL, MN--(Marketwire - June 29, 2009) - Jet Edge, Inc. will showcase its latest innovations in waterjet cutting and ultra-high pressure surface preparation technology at the WaterJet Technology Association's 2009 American WJTA Conference and Expo, Aug. 18-20, at the Marriott Westchase Hotel in Houston, Texas. Look for Jet Edge in Hall A Booth 209.

Visitors to the Jet Edge booth will learn about Jet Edge's mobile and precision waterjet products, including its 90,000 psi (6,200 bar) waterjet intensifier pump technology, its new Hydraulic Versacutter portable abrasive waterjet cutting and beveling system, and the Jet Edge Mid Rail Gantry precision waterjet cutting machine. Jet Edge also will showcase its ultra-high pressure

BrightTALK Hosts eHealth Summit

Mon, 29 Jun 2009 12:30:00 EDT

Interact With eHealth Experts Live on BrightTALK

Daytop Enhances Client Intake Program and Ensures HIPAA Compliance With Open Source ProcessMaker

Mon, 29 Jun 2009 11:35:00 EDT

Daytop Village of New Jersey (Daytop-NJ), a Residential Substance Abuse Treatment and Education Program, Manages Workflow for Its Intake and Assessment Programs With Colosa's ProcessMaker

Amarillo Biosciences and CytoPharm Announce Start of Enrollment for Hepatitis C Study in Taiwan

Mon, 29 Jun 2009 11:09:00 EDT

AMARILLO, TX--(Marketwire - June 29, 2009) - Amarillo Biosciences, Inc. (ABI) (OTCBB: AMAR) and CytoPharm, Inc. today jointly announced the start of enrollment for a study of ABI's oral interferon-alpha lozenges for chronic hepatitis C virus infection. The aim of the trial is to reduce the virologic relapse rate for those patients who have completed the standard combination therapy, which consists of high dose injectable interferon-alpha and Ribavirin. Although most patients respond to the standard therapy, up to 50% of those with certain "high-risk" viral genotypes relapse after treatment.

Health Care Industry Will Undergo a Revolution in Automation by 2014

Mon, 29 Jun 2009 11:08:00 EDT

ROCKVILLE, MD--(Marketwire - June 29, 2009) - MarketResearch.com has announced the addition of TowerGroup's new report "Banks Supporting Health Care Automation: Improving the Revenue Cycle for Health Care Providers," to their collection of Banking & Financial Services market reports. For more information, visit http://www.marketresearch.com/redirect.asp?progid=67618&productid=2261294

The US health care industry will undergo a revolution in automation before 2014. Health care providers represent an important market segment for banks' wholesale revenue streams.

Eco-Atkins Diet May Reduce Heart Disease Risk Factors; Study Supported by Solae and Canada Research Chair Funding

Mon, 29 Jun 2009 10:17:00 EDT

ST. LOUIS, MO--(Marketwire - June 29, 2009) - A new study shows a vegetarian version of the Atkins low-carbohydrate diet may help people lose weight and lower levels of bad (or, LDL) cholesterol in the blood. The traditional Atkins diet consists of low carbohydrate foods and a high intake of animal protein. Although studies to date have shown the traditional Atkins diet may produce modest weight loss, these studies have not demonstrated a reduction in the major heart disease risk factor, LDL or "bad" cholesterol levels.

Transaction in Own Shares

Mon, 29 Jun 2009 09:28:00 EDT

BAGSV�RD, DENMARK--(Marketwire - June 29, 2009) - Novo Nordisk A/S - Share repurchase programme

On 29 January 2009, Novo Nordisk initiated its share repurchase programme in accordance with the provisions of the European Commission's regulation no 2273/2003 of 22 December 2003, also referred to as the Safe Harbour rules.

Under the programme Novo Nordisk will repurchase B shares for an amount up to DKK 3.0 billion in the period from 29 January 2009 to 5 August 2009.

New Uni-Ter Website Introduces Management and Creative Services

Mon, 29 Jun 2009 09:00:00 EDT

ATLANTA, GA--(Marketwire - June 29, 2009) - Uni-Ter Underwriting Management Corporation (UUMC) has just brought a new, state-of-the-art website online, www.uni-ter.com, to introduce the Company's management and creative services to the insurance industry, Sanford "Sandy" Elsass, President/CEO, announced.

Uni-Ter is a managing general underwriter and insurance services firm that builds and manages Risk Retention Groups and other Alternative Risk Transfer insurance mechanisms in the healthcare field. It is a subsidiary of U.S. RE Companies, Inc., the New York-based, international financial services firm.

T.N.T Designs, Inc. Announces Bay City Transfer Agency and Registrar as New Transfer Agent

Mon, 29 Jun 2009 09:00:00 EDT

BAY CITY, MI--(Marketwire - June 29, 2009) - T.N.T. Designs, Inc. ("T.N.T." or "The Company") (OTCBB: TNTD) announced that effective June 18, 2009 it has retained the services of Bay City Transfer Agency and Registrar as its new transfer agent.

Safe Harbor This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 (The "Act"). In particular, when used in the preceding discussion, the words "pleased" "plan," "confident that," "believe," "expect," or "intend to," and similar conditional expressions are intended to identify forward looking statements within the meaning of the Act and are subject to the safe harbor created by the Act. Such statements are subject to certain risks and uncertainties and actual results could differ materially from those expressed in any of the forward-looking statements. Such risks and uncertainties include, but are not l

The Jean Coutu Group (PJC) Inc. Annual General Meeting of Shareholders

Mon, 29 Jun 2009 08:54:00 EDT

LONGUEUIL, QUEBEC--(Marketwire - June 29, 2009) - The Jean Coutu Group (PJC) Inc. (the "Company" or the "Jean Coutu Group") (TSX:PJC.A) wishes to remind the public that its Annual General Meeting of Shareholders will be held on Tuesday July 7, 2009, at 9:30 am ET at the Head Office of the Company, 551 Beriault Street, Longueuil, Quebec. The Meeting will also be webcast on the corporate website at www.jeancoutu.com. Representatives of the Jean Coutu Group will meet the press after the Meeting.

Le Groupe Jean Coutu (PJC) inc. assembl�e g�n�rale annuelle des actionnaires

Mon, 29 Jun 2009 08:54:00 EDT

LONGUEUIL, QUEBEC--(Marketwire - 29 juin 2009) - Le Groupe Jean Coutu (PJC) inc. (La "Compagnie" ou le "Groupe Jean Coutu") (TSX:PJC.A) d�sire rappeler que l'assembl�e g�n�rale annuelle des actionnaires aura lieu mardi le 7 juillet 2009 � 9 h 30 HE au si�ge social de la Compagnie situ� au 551, rue B�riault � Longueuil, Qu�bec. Cette assembl�e sera �galement diffus�e sur le site Internet de la Compagnie � l'adresse suivante www.jeancoutu.com. Les dirigeants du Groupe Jean Coutu rencontreront les repr�sentants des m�dias imm�diatement apr�s l'assembl�e.

The Jean Coutu Group To Hold First Quarter 2010 Results Conference Call

Mon, 29 Jun 2009 08:48:00 EDT

LONGUEUIL, QUEBEC--(Marketwire - June 29, 2009) - The Jean Coutu Group (PJC) Inc. (TSX:PJC.A) announced today that the release of results for the first quarter of fiscal 2010 will take place on July 7, 2009 at approximately 7:00 a.m. ET. Financial analysts and investors are invited to attend a conference call during which the financial results will be presented. /T/ Time and date: Tuesday, July 7, 2009 at 8:30 a.m. ET Dial number: 514-861-2909 or 1 877-695-6175 Access code 4728755 followed by pound sign (#)

Appel conf�rence du Groupe Jean Coutu : R�sultats du premier trimestre de l'exercice financier 2010

Mon, 29 Jun 2009 08:48:00 EDT

LONGUEUIL, QUEBEC--(Marketwire - 29 juin 2009) - Le Groupe Jean Coutu (PJC) inc. (TSX:PJC.A) annonce que la divulgation des r�sultats du premier trimestre de l'exercice financier 2010 aura lieu le 7 juillet 2009, aux environs de 7 h 00 HE. Les analystes financiers et investisseurs sont invit�s � participer � une conf�rence t�l�phonique au cours de laquelle les r�sultats financiers seront pr�sent�s. /T/ Date et heure: Mardi le 7 juillet 2009 � 8 h 30 HE Num�ro � composer: 514-861-2909 ou 1 877-695-6175

TearLab Corporation Announces Change in Company Leadership

Mon, 29 Jun 2009 08:45:00 EDT

SAN DIEGO, CALIFORNIA--(Marketwire - June 29, 2009) - OccuLogix, Inc. dba TearLab Corporation (NASDAQ:TEAR)(TSX:TLB) today announced that its Chief Executive Officer, Eric Donsky, is leaving the company to pursue other opportunities effective immediately. The Company's Board of Directors has appointed its Chairman, Elias Vamvakas, to serve as Interim Chief Executive Officer until a permanent replacement for Mr. Donsky can be found. "TearLab Corporation has achieved a number of important milestones in recent months, not the least of which was FDA 510(k) clearance of our award-winning TearLab(TM) Osmolarity System," commented Company director, Donald Rindell. "On behalf of the Board, I would like to take this opportunity to thank Eric for his dedication and many valuable contributions. Eric founded OcuSense with Dr. Benjamin Sullivan in 2003 and remained CEO through its merger with Occulogix in October 2008."

MMR Information Systems Shows Sharp Increase in Affinity Group and Corporate Usage

Mon, 29 Jun 2009 08:35:00 EDT

Nearly 500,000 Users With Access to the MyMedicalRecords Personal Health Record and MyEsafeDepositBox.com Virtual Vault

When It Comes to Your Eyes, Make It Home Safe Home

Mon, 29 Jun 2009 08:30:00 EDT

Results of American Academy of Ophthalmology's Sixth Annual Eye Injury Snapshot Finds Nearly Half of Eye Injuries Occur in the Home From Everyday Projects

Importance of Wearing Protective Eyewear Focus of New Public Service Announcement From PBS Master Carpenter Norm Abram

Healthagen Launches Smart Phone Version of iTriage; Expands to Provide More Consumers With Actionable Healthcare Information

Mon, 29 Jun 2009 08:14:00 EDT

iTriage Now Provides Access to Over 500,000 Physicians in the Country; Available Free to iPhone Users

Statement from the International Diabetes Federation Related to Studies Published in Diabetelogia Suggesting Possible Link Between Insulin Glargine and Cancer

Mon, 29 Jun 2009 08:12:00 EDT

BRUSSELS, BELGIUM--(Marketwire - June 29, 2009) - The International Diabetes Federation (IDF) today called for urgent assessment and responses from regulatory authorities into a possible link between the use of insulin glargine (an insulin analogue) and increased risk of cancer based on findings published on 26 June, 2009 in Diabetelogia, the journal of the European Association for the Study of Diabetes (EASD).

Healthcare Expert Vita Cassese Joins Exigen Capital

Mon, 29 Jun 2009 08:00:00 EDT

Former VP of Business Development and Innovation at Pfizer to Focus on Building Business in Healthcare Sector

Prevent Blindness America Approves PediaVision Assessment Solution

Mon, 29 Jun 2009 08:00:00 EDT

Supported by Studies in Journal of American Academy of Pediatric Ophthalmology, and Binocular Vision and Strabismus Quarterly; PediaVision Screening Device Passes Rigorous Tests Based Upon ATS, VIP, or AAP Protocol

CareVirginia Seeks to Build Comprehensive Senior Living and Nursing Care Facility in Abingdon

Mon, 29 Jun 2009 08:00:00 EDT

Community-Based Company Plans to Extend Owner-Operated Quality Senior Care Into Washington and Smyth Counties

Micro Imaging Technology Signs Partner to Expand Sales and Manufacturing to Asia

Mon, 29 Jun 2009 07:30:00 EDT

SAN CLEMENTE, CA--(Marketwire - June 29, 2009) - Micro Imaging Technology, Inc. (OTCBB: MMTC) announced that it has entered into a strategic business development relationship with OPH Ltd. Hong Kong who will be instrumental in securing a manufacturing partner for the Company in Asia. In addition, OPH will develop this market for the MIT 1000 Rapid Microbial Identification System through its distribution channels by working closely with existing Micro Imaging Technology (MIT) distributors and jointly with MIT to identify and select other strategic partners to expand the Company's MIT 1000 business in Asia.

FONAR Granted Additional NASDAQ Extension

Mon, 29 Jun 2009 07:00:00 EDT

MELVILLE, NY--(Marketwire - June 29, 2009) - FONAR Corporation (NASDAQ: FONR), the Inventor of MR Scanning�, today announced that the NASDAQ Listing and Hearing Review Council (the "Listing Council") has determined to continue the listing of the Company's securities on The NASDAQ Capital Market, subject to the condition that, on or before October 5, 2009, the Company evidence compliance with NASDAQ's net income requirement by evidencing a minimum of $500,000 in net income for the fiscal year ending June 30, 2009.

Online Health Insurance Shoppers Indicate High Customer Satisfaction in Consumer Survey

Mon, 29 Jun 2009 07:00:00 EDT

A Recent Consumer Survey Conducted by GoHealthInsurance.com Finds High Satisfaction Among Online Shoppers and Learns Almost One-Third of Customers Who Visit GoHealth Insurance's Website Purchase a Health Policy That Fits Their Needs

Heathrow Natural Food & Beverage, Inc. Adds Distribution for Australia

Mon, 29 Jun 2009 07:00:00 EDT

LAKE MARY, FL--(Marketwire - June 29, 2009) - Heathrow Natural Food & Beverage, Inc. (PINKSHEETS: HRNF) is pleased to announce it has completed another distribution agreement for its Super Food brand ACAI Plus functional chewing gum for distribution in Australia. ACAI Plus functional chewing gum will give Australians a healthy and natural choice for the delivery of super high anti-oxidants equivalent to 17,000 ORAC (www.oracvalues.com) in two Chiclets. This level of anti-oxidant is absorbed at the cell level and cleans out free radicals from the body which cause a multitude of conditions, including inflammation, stress, fatigue, etc.

Hypoglycemia Increases Mortality Risk, Lengthens Hospital Stay for Diabetes Patients -- Even Outside the ICU

Mon, 29 Jun 2009 00:01:00 EDT

ALEXANDRIA, VA--(Marketwire - June 29, 2009) - Diabetes patients who are hospitalized for non-critical illnesses, and develop hypoglycemia while hospitalized, are likely to remain hospitalized longer and face greater risk of mortality both during and after hospitalization, according to a study published in the July issue of Diabetes Care.

This retrospective cohort study of more than 4,300 admissions, by researchers at Boston's Brigham and Women's Hospital, was the first to examine mortality risks for hospitalized diabetes patients outside a critical care setting. Previous research found an association between hypoglycemia in ICU patients and an increased risk of morality, seizures and coma.

Research Update

Sun, 28 Jun 2009 05:34:00 EDT

BAGSVAERD, DENMARK--(Marketwire - June 28, 2009) - Novo Nordisk insulin analogues have proven safety profiles

On Friday 26 June, Diabetologia, the journal of the European Association for the Study of Diabetes (EASD) published online data from four studies relating to a possible link between a long-acting insulin analogue, insulin glargine, and cancer1. As a basis for such a possible link, an accompanying editorial explains that certain insulin analogues have a structure making them more likely to bind to the IGF-1 receptor which is known to be involved in promoting tumour growth2.

Aegis Creates Over 1,000 New Jobs in the U.S. to Support a Leading Healthcare Provider

Sat, 27 Jun 2009 14:20:00 EDT

Aegis to Hire in Irving and Sierra Vista

Riverside Medical Center Offers Aromatherapy Workshop in July

Fri, 26 Jun 2009 23:49:00 EDT

KANKAKEE, IL--(Marketwire - June 26, 2009) - Riverside Medical Center is now adding an aromatherapy workshop to their human wellness repertoire. This workshop will benefit patients, their families, or anyone else who could use a little down time. The Wellness Aromatherapy Workshop will be held at Riverside Health Fitness Center in Bourbonnais on Wednesday, July 15, 2009.

Established in 1964 as a not-for-profit medical facility, Riverside HealthCare offers complete family care in nine communities throughout the southern suburbs of Chicago. As far as Chicagoland healthcare goes, Riverside HealthCare provides the high quality of treatment that you would expect from a top rated hospital.

WEX Reports Year End Financial Results

Fri, 26 Jun 2009 19:47:00 EDT

VANCOUVER, BRITISH COLUMBIA--(Marketwire - June 26, 2009) - WEX Pharmaceuticals Inc. ("WEX" or the "Company") (TSX:WXI) reported major events and financial results for the fiscal year ended March 31, 2009. All amounts, unless specified otherwise, are in Canadian dollars. Major Events - In April 2008, the Company announced the enrolment and dosing of the first patient in a Canadian Phase III clinical trial of TTX in cancer-related pain (TEC-006). This multi-centre, randomized, double-blind, and placebo-controlled trial will include approximately 120 patients with moderate to severe cancer-related pain.

Wellness International Network Doubles Number of Incentive Trips for 2010

Fri, 26 Jun 2009 17:38:00 EDT

PLANO, TX--(Marketwire - June 26, 2009) - In a time when other companies are cutting back and canceling conventions and incentive trips, Wellness International Network Founders Ralph Oats and Cathy Oats are increasing the number of incentive trips in 2010.

Next month, Wellness International Network's top distributors and their families will be relaxing on a breathtaking, seven-day vacation aboard Royal Caribbean's Liberty of the Seas to San Juan, St. Maarten, Haiti and Miami. As part of the expanded incentives for 2010, Wellness International Network will be treating top distributors to travel getaways in April and October with luxurious accommodations, gorgeous scenery and plenty of pampering.

Statement From the American Diabetes Association Related to Studies Published in Diabetelogia Suggesting Possible Link Between Insulin Glargine and Cancer

Fri, 26 Jun 2009 16:45:00 EDT

Research Conflicting and Inconclusive; Patients Should Not Stop Using Insulin and Should Talk to Their Doctor